Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,723.13
(
0.35%
)
US TECH 100
24,137.60
(
0.51%
)
Dow Jones
47,058.80
(
0.24%
)
Brent Oil
100.76
(
2.50%
)
Bitcoin
74,814.93
(
-0.04%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

mcbio

Send PM Follow Ignore
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

mcbio

Re: DewDiligence post# 117070

Saturday, 03/26/2011 11:57:19 AM

Saturday, March 26, 2011 11:57:19 AM

Post# of 257253

Investors Overplay JAK Threat to Abbott's Humira

But do they underplay the SYK threat? LOL jk Nice article. ABT will still get theirs I'm sure. And there should still be a nice market for PFE, AZN/RIGL, and others if the JAK/SYK drugs get approved.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now